As of 2024-12-11, the Relative Valuation of Sana Biotechnology Inc (SANA) is (38.08) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.48 USD, the upside of Sana Biotechnology Inc based on Relative Valuation is -1635.4%.
The range of the Relative Valuation is (34.30) - (46.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.0x - 43.7x | 35.0x |
| Forward P/E multiples | 19.6x - 33.7x | 20.6x |
| Fair Price | (34.30) - (46.13) | (38.08) |
| Upside | -1482.9% - -1960.1% | -1635.4% |
| Date | P/E |
| 2024-12-06 | -1.68 |
| 2024-12-05 | -1.68 |
| 2024-12-04 | -1.91 |
| 2024-12-03 | -1.88 |
| 2024-12-02 | -2.08 |
| 2024-11-29 | -2.03 |
| 2024-11-27 | -1.86 |
| 2024-11-26 | -1.79 |
| 2024-11-25 | -1.81 |
| 2024-11-22 | -1.91 |
| 2024-11-21 | -1.72 |
| 2024-11-20 | -1.85 |
| 2024-11-19 | -1.72 |
| 2024-11-18 | -1.71 |
| 2024-11-15 | -1.77 |
| 2024-11-14 | -1.89 |
| 2024-11-13 | -1.94 |
| 2024-11-12 | -2.07 |
| 2024-11-11 | -2.11 |
| 2024-11-08 | -2.19 |
| 2024-11-07 | -2.26 |
| 2024-11-06 | -2.49 |
| 2024-11-05 | -2.48 |
| 2024-11-04 | -2.75 |
| 2024-11-01 | -2.67 |
| 2024-10-31 | -2.56 |
| 2024-10-30 | -2.67 |
| 2024-10-29 | -2.76 |
| 2024-10-28 | -2.86 |
| 2024-10-25 | -2.75 |
| 2024-10-24 | -2.78 |
| 2024-10-23 | -2.77 |
| 2024-10-22 | -2.85 |
| 2024-10-21 | -2.87 |
| 2024-10-18 | -3.09 |
| 2024-10-17 | -2.96 |
| 2024-10-16 | -3.09 |
| 2024-10-15 | -3.02 |
| 2024-10-14 | -2.93 |
| 2024-10-11 | -2.91 |
| 2024-10-10 | -2.80 |
| 2024-10-09 | -2.91 |
| 2024-10-08 | -2.98 |
| 2024-10-07 | -3.07 |
| 2024-10-04 | -3.09 |
| 2024-10-03 | -3.10 |
| 2024-10-02 | -3.18 |
| 2024-10-01 | -3.10 |
| 2024-09-30 | -3.04 |
| 2024-09-27 | -3.12 |